DNDN
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
CUSIP: 24823Q107HealthcareUS1 holder
Total Value
$11.11M
Total Shares
2.35M
Net Share Change
+2.35M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Miller Value Partners
$11.11M2.35M sharesNEW